Palisade Bio, Inc. (PALI)
1.24
+0.12
(+10.71%)
USD |
NASDAQ |
Nov 03, 16:00
1.24
0.00 (0.00%)
After-Hours: 16:24
Palisade Bio Market Cap : 215.26M for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 194.43M |
| October 30, 2026 | 201.37M |
| October 29, 2026 | 206.58M |
| October 28, 2026 | 206.58M |
| October 27, 2026 | 208.31M |
| October 26, 2026 | 213.52M |
| October 23, 2026 | 230.88M |
| October 22, 2026 | 234.35M |
| October 21, 2026 | 243.03M |
| October 20, 2026 | 248.24M |
| October 19, 2026 | 232.62M |
| October 16, 2026 | 244.77M |
| October 15, 2026 | 267.34M |
| October 14, 2026 | 256.92M |
| October 13, 2026 | 254.32M |
| October 12, 2026 | 276.02M |
| October 09, 2026 | 267.34M |
| October 08, 2026 | 251.71M |
| October 07, 2026 | 256.92M |
| October 06, 2026 | 258.66M |
| October 05, 2026 | 253.45M |
| October 02, 2026 | 249.98M |
| October 01, 2026 | 248.24M |
| September 30, 2026 | 234.35M |
| September 29, 2026 | 251.71M |
| Date | Value |
|---|---|
| September 28, 2026 | 260.39M |
| September 25, 2026 | 251.71M |
| September 24, 2026 | 272.54M |
| September 23, 2026 | 277.75M |
| September 22, 2026 | 293.38M |
| September 21, 2026 | 293.38M |
| September 18, 2026 | 276.02M |
| September 17, 2026 | 295.11M |
| September 16, 2026 | 293.38M |
| September 15, 2026 | 349.79M |
| September 14, 2026 | 355.87M |
| September 11, 2026 | 357.61M |
| September 10, 2026 | 348.93M |
| September 09, 2026 | 355.87M |
| September 08, 2026 | 381.91M |
| September 04, 2026 | 362.81M |
| September 03, 2026 | 355.00M |
| September 02, 2026 | 345.45M |
| September 01, 2026 | 340.25M |
| August 31, 2026 | 338.51M |
| August 28, 2026 | 347.19M |
| August 27, 2026 | 366.29M |
| August 26, 2026 | 369.76M |
| August 25, 2026 | 359.34M |
| August 24, 2026 | 348.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.541B |
| Alnylam Pharmaceuticals, Inc. | 21.40B |
| Anika Therapeutics, Inc. | 258.83M |
| Savara, Inc. | 974.62M |
| Vericel Corp. | 2.102B |
Market Cap Related Metrics
| PS Ratio | 364.54 |
| Price to Book Value | 1.768 |
| Price | 1.24 |
| Earnings Yield | -43.17% |